SEPAWA 2026: Home care innovators target sustainability and multifunctionality
Personal care players at the ongoing SEPAWA (Soap, Perfume, Cosmetic, and Detergent Specialists) Congress 2026, in Berlin, Germany (October 14–16) are highlighting multifunctional and sustainability-focused home care innovations.
Yunnan launches sugarcane mechanisation and by-product innovation projects
Yunnan is stepping up efforts to improve the competitiveness of its sugar industry through two new research and developm…
Lanfeng Biochemical plans RMB300 Million share placement to reduce debt
Jiangsu Lanfeng Biochemical Co., Ltd. plans to raise up to RMB300 million through a private placement of A-shares, direc…
BioNTech’s mRNA cancer vaccine misses Phase 2/3 endpoint
Why it matters: mRNA cancer immunotherapies are a central part of BioNTech’s oncology strategy. The result raises the pressure to demonstrate clinical benefit, although the ongoing trial could still succeed through its second primary endpoint: overall survival.
Kenyan Agritech Startup Rhea Raises $100,000 for Tanzania Expansion
49 Kenyan Agritech startup Rhea has raised US$100,000 from Obudu Capital to support its expansion into Tanzania. The fun…
China’s PBAT prices rise as raw material costs collide with oversupply
China’s biodegradable plastics industry is confronting a familiar industrial dilemma: rising production costs are forcin…
PerPlant lands Valtra deal to put its AI crop sensor on tractors straight from the factory
Danish agtech startup PerPlant’s AI crop sensor is now available factory-fitted onto new Valtra tractors through a partn…
Revieve launches Beauty LLM Suite for AI assistant era
Revieve has introduced the Revieve Beauty LLM (large language model) Suite to understand the relationships between people, skin, ingredients, products, routines, behaviors, and brands.
OlsAro raises $5.5m seed round as salt-tolerant wheat nears market
[Disclosure: AgFunderNews’ parent company AgFunder is an investor in OlsAro.] OlsAro—a Swedish startup developing salt t…
Zealand taps Generate’s AI discovery engine in $1.2B obesity deal
Why it matters: The deal adds another source of potential candidates as recent results from Zealand’s major partnered drugs raise questions about their competitiveness. It continues a diversification strategy already underway before those readouts.